PL EN


2009 | 1(24) | 53-65
Article title

AVAILABILITY OF CANCER DRUGS IN POLAND IN COMPARISON WITH OTHER EUROPEAN COUNTRIES (Dostepnosc leków onkologicznych w Polsce na tle krajów europejskich(

Title variants
Languages of publication
PL
Abstracts
EN
This paper presents different aspects of burden of cancer to individual, society and economy in terms of incidence, mortality as well as direct and indirect costs associated with cancer. European and Polish cancer incidence is increasing and mortality decreasing indicating the impact of screening programs and improvements in treatment. Spending on cancer is increasing but too low and still not in parity with the relative burden of cancer compared to other diseases. Accessibility to cancer drugs (especially innovative drugs) is not sufficient in Poland and in comparison to European countries. The public spending on cancer drugs is increasing but at too low rate.
Year
Issue
Pages
53-65
Physical description
Document type
ARTICLE
Contributors
  • Ewelina Nojszewska, Szkola Glówna Handlowa w Warszawie, Kolegium Gospodarki Swiatowej, Katedra Ekonomii II, al. Niepodleglosci 162, 02-554 Warszawa, Poland
References
Document Type
Publication order reference
Identifiers
CEJSH db identifier
10PLAAAA08214
YADDA identifier
bwmeta1.element.5545f656-6a81-3e63-ab11-cdfbb92db6ff
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.